Showing results (2451-2460 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The Lancet. Infectious Diseases|June 15, 2024
Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and controlMei Kang, Li-Fang Wang, Bo-Wen Sun, et al.
The Lancet. Infectious Diseases|June 16, 2024
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort studyOleksandr Korotych, Jay Achar, Elmira Gurbanova, et al.
The Lancet. Infectious Diseases|May 18, 2024
Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational studyIda Rask Moustsen-Helms, Peter Bager, Tine Graakjær Larsen, et al.
The Lancet. Infectious Diseases|August 25, 2023
Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort studyDimie Ogoina, Mahmood Muazu Dalhat, Ballah Akawu Denue, et al.
The Lancet. Infectious Diseases|August 21, 2023
Resurgence of congenital syphilis: new strategies against an old foePhilip Moseley, Alasdair Bamford, Sarah Eisen, et al.
The Lancet. Infectious Diseases|August 14, 2023
Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trialJames Peterson, Daniel Drazan, Hanna Czajka, et al.
The Lancet. Infectious Diseases|October 1, 2023
Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implicationsCarmela Pinnetti, Eleonora Cimini, Valentina Mazzotta, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
The Lancet. Infectious Diseases|July 10, 2023
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveysKatherine E Gallagher, Ifedayo M O Adetifa, Caroline Mburu, et al.
Pageof 270